TENX Financials

Tenax Therapeutics Inc - Financial statements & key metrics

Stock Price

$1.79

Market Cap

$24.06M

P/E Ratio

3.4

EPS

$-1.15

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-17.60M

EPS (Diluted)

$-1.15

Balance Sheet Highlights

Total Assets

$96.69M

Total Liabilities

$4.69M

Shareholders Equity

-

Cash & Equivalents

$94.90M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-14.81M

CapEx

-

Free Cash Flow

-

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is TENX revenue?

View TENX's income statement for detailed revenue data.

Is TENX profitable?

TENX reported a loss of $17.60M in the most recent quarter.

What is TENX market cap?

TENX has a market capitalization of $24.06M, making it a small-cap stock.

Does TENX have debt?

View TENX's balance sheet for debt information.

What is TENX cash flow?

Cash flow data is available in the full financial statements.

Explore Categories